id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0301-0006,FDA,FDA-2004-D-0301,"Guidance for Industry on Fixed Dose Combina.tions, Co-Packaged Drug
Products, and Single-Entity Versions of Previously Approved Antiretrovirals
for the Treatment of HIV; Availability",Notice,NAD-Notice of Availability of Data,2006-10-18T04:00:00Z,2006,10,2006-10-17T04:00:00Z,2007-10-19T03:59:59Z,2020-09-10T17:30:49Z,,0,0,0900006480472ddf
FDA-2004-D-0301-0005,FDA,FDA-2004-D-0301,"Guidance for Industry Fixed Dose Combinations, Co-Packaged Drug Products, and Single-EntityVersions of Previously Approved
Antiretrovirals for the Treatment of HIV",Other,Guidance,2006-10-18T04:00:00Z,2006,10,,,2020-09-10T19:00:16Z,,0,0,0900006480472dde